Animesh D Pardanani, MBBS, PhD

  • 19491 Citations
  • 77 Scopus h-Index
1993 …2020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1993 2020

2020

Prevalence and spectrum of T-cell lymphoproliferative disorders in patients with Hypereosinophilia: A reference laboratory experience

Shi, M., Rech, K. L., Otteson, G. E., Horna, P., Olteanu, H., Pardanani, A., Chen, D. & Jevremovic, D., Feb 2020, In : Annals of Diagnostic Pathology. 44, 151412.

Research output: Contribution to journalReview article

Lymphoproliferative Disorders
T-Lymphocytes
T-Lymphocyte Gene Rearrangement
T-Cell Receptor Genes
Eosinophils
2019
5 Citations (Scopus)

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Szuber, N., Mudireddy, M., Nicolosi, M., Penna, D., Vallapureddy, R. R., Lasho, T. L., Finke, C., Begna, K., Elliott, M. A., Hook, C. C., Wolanskyj, A. P., Patnaik, M. M., Hanson, C. A., Ketterling, R. P., Sirhan, S., Pardanani, A. D., Gangat, N., Busque, L. & Tefferi, A., Jan 1 2019, In : Mayo Clinic proceedings.

Research output: Contribution to journalArticle

Polycythemia Vera
Essential Thrombocythemia
Primary Myelofibrosis
Survival
Neoplasms
1 Citation (Scopus)

A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy

Gangat, N., Phelps, A., Lasho, T. L., Finke, C. M., Vallapureddy, R., Hanson, C. A., Ketterling, R. P., Patnaik, M. M., Pardanani, A. D. & Tefferi, A., Feb 1 2019, In : Blood Cancer Journal. 9, 2, 11.

Research output: Contribution to journalLetter

Thiamine
Neoplasms
Therapeutics

Calculator-free point-of-care prognostication in myelodysplastic syndromes

Tefferi, A., Hanson, C. A., Ketterling, R. P., Pardanani, A. D. & Gangat, N., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Point-of-Care Systems
Myelodysplastic Syndromes
5 Citations (Scopus)

Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation

Patnaik, M. M., Pophali, P. A., Lasho, T. L., Finke, C. M., Horna, P., Ketterling, R. P., Gangat, N., Mangaonkar, A. A., Pardanani, A. D. & Tefferi, A., Jun 1 2019, In : Haematologica. 104, 6, p. e236-e239

Research output: Contribution to journalLetter

Open Access
Leukemia, Myelomonocytic, Chronic
Mutation
Survival

Cytogenetic clonal evolution in myeloproliferative neoplasms: contexts and prognostic impact among 648 patients with serial bone marrow biopsies

Tefferi, A., Nicolosi, M., Penna, D., Vallapureddy, R., Hanson, C. A., Pardanani, A. D., Gangat, N. & Ketterling, R. P., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalLetter

Clonal Evolution
Cytogenetics
Bone Marrow
Biopsy
Neoplasms

Essential thrombocythemia

Tefferi, A. & Pardanani, A., Nov 28 2019, In : New England Journal of Medicine. 381, 22, p. 2135-2144 10 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Etiologies of Extreme Thrombocytosis: A Contemporary Series

Hsieh, R. W., Ravindran, A., Hook, C. C., Begna, K., Ashrani, A. A., Pruthi, R. K., Marshall, A. L., Hogan, W., Litzow, M. R., Hoyer, J., Oliveira, J., Vishnu, P., Call, T. G., Al-Kali, A., Patnaik, M. M., Gangat, N., Pardanani, A. D., Tefferi, A. & Go, R. S., Aug 1 2019, In : Mayo Clinic proceedings. 94, 8, p. 1542-1550 9 p.

Research output: Contribution to journalArticle

Thrombocytosis
Hematologic Neoplasms
Outpatients
Inpatients
Splenectomy

Functional evaluation of isocitrate dehydrogenase 1 and 2 variants of unclear significance in chronic myeloid neoplasms

Tischer, A., Antelo, G., Coltro, G., Finke, C. M., Gonsalves, W., Pardanani, A., Ketterling, R., Mangaonkar, A., Gangat, N., Tefferi, A., Patnaik, M. M. & Lasho, T. L., Dec 2019, In : Leukemia Research. 87, 106264.

Research output: Contribution to journalLetter

Isocitrate Dehydrogenase
Neoplasms
Open Access
Thrombocytosis
Myelodysplastic Syndromes
Neoplasms

Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model

Vallapureddy, R. R., Mudireddy, M., Penna, D., Lasho, T. L., Finke, C. M., Hanson, C. A., Ketterling, R. P., Begna, K., Gangat, N., Pardanani, A. D. & Tefferi, A., Feb 1 2019, In : Blood Cancer Journal. 9, 2, 12.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Mutation
Anemia
Incidence
Karyotype

Phenotypic heterogeneity associated with germline GATA2 haploinsufficiency: a comprehensive kindred study

Haddox, C. L., Carr, R. M., Abraham, R. S., Perez Botero, J., Rodriguez, V., Pardanani, A. D. & Patnaik, M. M., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

Haploinsufficiency
8 Citations (Scopus)

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients

Coston, T., Pophali, P., Vallapureddy, R., Lasho, T. L., Finke, C. M., Ketterling, R. P., Carr, R., Binder, M., Mangaonkar, A. A., Gangat, N., Al-Kali, A., Litzow, M. R., Zblewski, D., Pardanani, A. D., Tefferi, A. & Patnaik, M. M., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Myelodysplastic Syndromes
decitabine
Survival
Therapeutics
1 Citation (Scopus)

World Health Organization class-independent risk categorization in mastocytosis

Pardanani, A. D., Lasho, T. L., Reichard, K. K., Hanson, C. A. & Tefferi, A., Mar 1 2019, In : Blood cancer journal. 9, 3, 29.

Research output: Contribution to journalLetter

Open Access
Mastocytosis
2018

20+ Years and alive with primary myelofibrosis: Phenotypic signature of very long-lived patients

Penna, D., Lasho, T. L., Finke, C. M., Vallapureddy, R. R., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Survival
Platelet Count
Leukocyte Count
Genetic Markers
10 Citations (Scopus)

A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone

Patnaik, M. M., Rangit Vallapureddy, V., Lasho, T. L., Hoversten, K. P., Finke, C. M., Ketterling, R. P., Hanson, C. A., Gangat, N., Tefferi, A. & Pardanani, A. D., Apr 2 2018, (Accepted/In press) In : Leukemia. p. 1-6 6 p.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Systemic Mastocytosis
1 Citation (Scopus)

A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status

Begna, K., Ali, W., Gangat, N., Elliott, M. A., Al-Kali, A., Litzow, M. R., Hook, C. C., Wolanskyj, A. P., Hogan, W., Patnaik, M. M., Pardanani, A. D., Zblewski, D. L., Chen, D., He, R., Viswanatha, D., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Karyotype
Acute Myeloid Leukemia

A retrospective survey of exposure history to chemotherapy or radiotherapy in 940 consecutive patients with primary myelofibrosis

Nicolosi, M., Mudireddy, M., Patnaik, M. M., Gangat, N., Pardanani, A. D. & Tefferi, A., Apr 1 2018, In : American Journal of Hematology. 93, 4, p. E103-E107

Research output: Contribution to journalLetter

Primary Myelofibrosis
Radiotherapy
History
Drug Therapy
Surveys and Questionnaires
2 Citations (Scopus)

A test utilization approach to the diagnostic workup of isolated eosinophilia in otherwise morphologically unremarkable bone marrow: A single institutional experience

Fang, H., Ketterling, R. P., Hanson, C. A., Pardanani, A. D., Kurtin, P. J., Chen, D., Greipp, P. T., Howard, M. T., King, R., Van Dyke, D. L. & Reichard, K. K., Oct 1 2018, In : American Journal of Clinical Pathology. 150, 5, p. 421-431 11 p.

Research output: Contribution to journalArticle

Eosinophilia
Bone Marrow
Platelet-Derived Growth Factor beta Receptor
Systemic Mastocytosis
Hypereosinophilic Syndrome
3 Citations (Scopus)

Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms

Patnaik, M. M., Lasho, T., Howard, M., Finke, C., Ketterling, R. L., Al-Kali, A., Pardanani, A. D., Droin, N., Gangat, N., Tefferi, A. & Solary, E., Sep 1 2018, In : Blood Cancer Journal. 8, 9, 82.

Research output: Contribution to journalLetter

Leukemia, Myelomonocytic, Chronic
Retinoblastoma Genes
Dendritic Cells
Neoplasms
16 Citations (Scopus)

Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts

Tefferi, A., Mudireddy, M., Mannelli, F., Begna, K., Patnaik, M. M., Hanson, C. A., Ketterling, R. P., Gangat, N., Yogarajah, M., de Stefano, V., Passamonti, F., Rosti, V., Finazzi, M. C., Rambaldi, A., Bosi, A., Guglielmelli, P., Pardanani, A. D. & Vannucchi, A. M., Feb 2 2018, (Accepted/In press) In : Leukemia. p. 1-11 11 p.

Research output: Contribution to journalArticle

Blast Crisis
Stem Cells
Transplants
Survival
Neoplasms
2 Citations (Scopus)

CSF3R-mutated chronic neutrophilic leukemia: Long-term outcome in 19 consecutive patients and risk model for survival

Szuber, N., Finke, C. M., Lasho, T. L., Elliott, M. A., Hanson, C. A., Pardanani, A. D. & Tefferi, A., Feb 1 2018, In : Blood Cancer Journal. 8, 2, 21.

Research output: Contribution to journalLetter

Leukemia, Neutrophilic, Chronic
Survival
3 Citations (Scopus)

Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases

Shah, S., Pardanani, A. D., Elala, Y. C., Lasho, T. L., Patnaik, M. M., Reichard, K. K., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Systemic Mastocytosis
Chromosome Aberrations
Incidence
Abnormal Karyotype
Mast-Cell Leukemia
5 Citations (Scopus)

Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance

Barraco, D., Cerquozzi, S., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Aug 1 2018, In : British Journal of Haematology. 182, 3, p. 437-440 4 p.

Research output: Contribution to journalLetter

Polycythemia Vera
Cytogenetics

Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide

Tefferi, A., Szuber, N., Vallapureddy, R. R., Begna, K., Patnaik, M. M., Elliott, M. A., Christopher Hook, C., Wolanskyj, A. P., Hanson, C. A., Ketterling, R. P., Pardanani, A. D. & Gangat, N., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Essential Thrombocythemia
Survival Rate
Primary Myelofibrosis
Survival
Busulfan

Determinants of long-term outcome in type 1 calreticulin-mutated myelofibrosis

Szuber, N., Lasho, T. L., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Calreticulin
Primary Myelofibrosis
2 Citations (Scopus)

Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels

Tefferi, A., Nicolosi, M., Penna, D., Mudireddy, M., Szuber, N., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Gangat, N. & Pardanani, A. D., Aug 14 2018, In : Blood Advances. 2, 15, p. 1980-1984 5 p.

Research output: Contribution to journalArticle

Open Access
Primary Myelofibrosis
Cachexia
Serum Albumin
Cholesterol
2 Citations (Scopus)

Early thrombotic events and preemptive systemic anticoagulation following splenectomy for myelofibrosis

Mudireddy, M., Gangat, N., Lasho, T. L., Finke, C., Hanson, C. A., Ketterling, R. P., Ashrani, A. A., Pardanani, A. D., Nagorney, D. M. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Splenectomy

Genetic predictors of response to specific drugs in primary myelofibrosis

Penna, D., Szuber, N., Lasho, T. L., Finke, C. M., Vallapureddy, R. R., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Nov 19 2018, In : Blood Cancer Journal. 8, 12, 1 p.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Pharmaceutical Preparations
5 Citations (Scopus)

Genotype–phenotype correlation of hereditary erythrocytosis mutations, a single center experience

Oliveira, J., Coon, L. M., Frederick, L. A., Hein, M., Swanson, K. C., Savedra, M. E., Porter, T. R., Patnaik, M. M., Tefferi, A., Pardanani, A. D., Grebe, S. K., Viswanatha, D. S. & Hoyer, J., Aug 1 2018, In : American Journal of Hematology. 93, 8, p. 1029-1041 13 p.

Research output: Contribution to journalArticle

Hemoglobins
Mutation
Oxygen
2,3-Diphosphoglycerate
Restless Legs Syndrome
32 Citations (Scopus)

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis

Tefferi, A., Guglielmelli, P., Nicolosi, M., Mannelli, F., Mudireddy, M., Bartalucci, N., Finke, C. M., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Begna, K., Naseema Gangat, G., Pardanani, A. D. & Vannucchi, A. M., Mar 23 2018, (Accepted/In press) In : Leukemia. p. 1-12 12 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Mutation
Karyotype
Survival
Genetic Markers
5 Citations (Scopus)

How I treat myelofibrosis after failure of JAK inhibitors

Pardanani, A. D. & Tefferi, A., Aug 2 2018, In : Blood. 132, 5, p. 492-500 9 p.

Research output: Contribution to journalArticle

Transplants
Primary Myelofibrosis
Patient treatment
Investigational Drugs
Salvaging
2 Citations (Scopus)

JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease

Tefferi, A., Lavu, S., Mudireddy, M., Lasho, T. L., Finke, C. M., Gangat, N., Pardanani, A. D., Hanson, C. A., Mannarelli, C., Guglielmelli, P. & Vannucchi, A. M., Apr 1 2018, In : American Journal of Hematology. 93, 4, p. E93-E96

Research output: Contribution to journalLetter

Polycythemia Vera
Exons
4 Citations (Scopus)

Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis

Pardanani, A. D., Gotlib, J., Roberts, A. W., Wadleigh, M., Sirhan, S., Kawashima, J., Maltzman, J. A., Shao, L., Gupta, V. & Tefferi, A., Apr 1 2018, In : Leukemia. 32, 4, p. 1034-1037 4 p.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Safety
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
12 Citations (Scopus)

Mast cell activation syndrome: Importance of consensus criteria and call for research

Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Broesby-Olsen, S., Brockow, K., Butterfield, J. H., Reiter, A., Gotlib, J., Castells, M., Milner, J. D., Carter, M. C., Komarow, H., Radia, D., Pardanani, A. D., Sotlar, K., Triggiani, M., Horny, H. P., Arock, M., Schwartz, L. B. & 1 others, Metcalfe, D. D., Jan 1 2018, (Accepted/In press) In : Journal of Allergy and Clinical Immunology.

Research output: Contribution to journalArticle

Mast Cells
Research
6 Citations (Scopus)

Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information

Tefferi, A., Gangat, N., Mudireddy, M., Lasho, T. L., Finke, C., Begna, K., Elliott, M. A., Al-Kali, A., Litzow, M. R., Hook, C. C., Wolanskyj, A. P., Hogan, W., Patnaik, M. M., Pardanani, A. D., Zblewski, D. L., He, R., Viswanatha, D., Hanson, C. A., Ketterling, R. P., Tang, J. L. & 5 others, Chou, W. C., Lin, C. C., Tsai, C. H., Tien, H. F. & Hou, H. A., Jan 1 2018, (Accepted/In press) In : Mayo Clinic Proceedings.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Taiwan
Karyotype
Mutation
Area Under Curve
9 Citations (Scopus)

Mayo alliance prognostic system for mastocytosis: Clinical and hybrid clinical-molecular models

Pardanani, A., Shah, S., Mannelli, F., Elala, Y. C., Guglielmelli, P., Lasho, T. L., Patnaik, M. M., Gangat, N., Ketterling, R. P., Reichard, K. K., Hanson, C. A., Vannucchi, A. M. & Tefferi, A., Nov 13 2018, In : Blood Advances. 2, 21, p. 2964-2972 9 p.

Research output: Contribution to journalArticle

Open Access
Systemic Mastocytosis
Mastocytosis
Molecular Models
Confidence Intervals
Mutation
3 Citations (Scopus)

Mayo CALR mutation type classification guide using alpha helix propensity

Lasho, T. L., Finke, C. M., Tischer, A., Pardanani, A. D. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Mutation
alpha-Helical Protein Conformation
87 Citations (Scopus)

MIPSS70: Mutation-enhanced international prognostic score system for transplantation-age patients with primary myelofibrosis

Guglielmelli, P., Lasho, T. L., Rotunno, G., Mudireddy, M., Mannarelli, C., Nicolosi, M., Pacilli, A., Pardanani, A. D., Rumi, E., Rosti, V., Hanson, C. A., Mannelli, F., Ketterling, R. P., Gangat, N., Rambaldi, A., Passamonti, F., Barosi, G., Barbui, T., Cazzola, M., Vannucchi, A. M. & 1 others, Tefferi, A., Feb 1 2018, In : Journal of Clinical Oncology. 36, 4, p. 310-318 9 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Transplantation
Mutation
Cytogenetics
Survival
29 Citations (Scopus)

MIPSS701 version 2.0: Mutation and karyotype-enhanced international prognostic scoring system for primary myelofibrosis

Tefferi, A., Guglielmelli, P., Lasho, T. L., Gangat, N., Ketterling, R. P., Pardanani, A. D. & Vannucchi, A. M., Jun 10 2018, In : Journal of Clinical Oncology. 36, 17, p. 1769-1770 2 p.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Karyotype
Mutation
5 Citations (Scopus)

Momelotinib therapy for myelofibrosis: A 7-year follow-up

Tefferi, A., Barraco, D., Lasho, T. L., Shah, S., Begna, K., Al-Kali, A., Hogan, W., Litzow, M. R., Hanson, C. A., Ketterling, R. P., Gangat, N. & Pardanani, A. D., Mar 1 2018, In : Blood Cancer Journal. 8, 3, 29.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Karyotype
Mutation
Survival
Peripheral Nervous System Diseases
9 Citations (Scopus)

Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis

Tefferi, A., Shah, S., Mudireddy, M., Lasho, T. L., Barraco, D., Hanson, C. A., Ketterling, R. P., Elliott, M. A., Patnaik, M. M., Pardanani, A. D. & Gangat, N., Dec 1 2018, In : British Journal of Haematology. 183, 5, p. 835-838 4 p.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Monocytes
2 Citations (Scopus)

MPL-mutated essential thrombocythemia: a morphologic reappraisal

Szuber, N., Hanson, C. A., Lasho, T. L., Finke, C., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Nov 20 2018, In : Blood Cancer Journal. 8, 12, 1 p.

Research output: Contribution to journalLetter

Essential Thrombocythemia
8 Citations (Scopus)

Mutations and karyotype predict treatment response in myelodysplastic syndromes

Idossa, D., Lasho, T. L., Finke, C. M., Ketterling, R. P., Patnaik, M. M., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Karyotype
Mutation
Therapeutics
Hematinics
15 Citations (Scopus)

Mutations and prognosis in myelodysplastic syndromes: Karyotype-adjusted analysis of targeted sequencing in 300 consecutive cases and development of a genetic risk model

Gangat, N., Mudireddy, M., Lasho, T. L., Finke, C. M., Nicolosi, M., Szuber, N., Patnaik, M. M., Pardanani, A. D., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Genetic Models
Myelodysplastic Syndromes
Karyotype
Mutation
Survival

Mutations and prognosis in myeloproliferative neoplasms

Tefferi, A. & Pardanani, A. D., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Mutation
Neoplasms
7 Citations (Scopus)

Myelofibrosis Treatment Algorithm 2018

Tefferi, A., Guglielmelli, P., Pardanani, A. D. & Vannucchi, A. M., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 72.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Cytogenetics
Mutation
Transplants
Therapeutics
8 Citations (Scopus)

Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger

Szuber, N., Vallapureddy, R. R., Penna, D., Lasho, T. L., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Neoplasms
Essential Thrombocythemia
Polycythemia Vera
Primary Myelofibrosis
Cytogenetics

Normal karyotype in myelofibrosis: Is prognostic integrity affected by the number of metaphases analyzed?

Nicolosi, M., Mudireddy, M., Gangat, N., Pardanani, A. D., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Jan 1 2018, In : Blood Cancer Journal. 8, 1, 8.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Metaphase
Karyotype

Practice-relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm

Tefferi, A., Shah, S., Lasho, T. L., Patnaik, M. M., Reichard, K. K., Hanson, C. A., Ketterling, R. P. & Pardanani, A. D., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Systemic Mastocytosis
Hematologic Neoplasms